Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · patients undergoing knee arthroscopy
3 findings from 1 review
no estimate extracted
2 studies · 72 participants
Very low
no estimate extracted
2 studies · 72 participants
Low
no estimate extracted
1 study · 39 participants
Low
Analgesia durationTime duration from the end of surgery to the time of first analgesic consumption. Scale from: 0 to 100. · patients undergoing knee arthroscopy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse eventsPercentage of participants with any adverse event · patients undergoing knee arthroscopy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Reported outcomes approximating to 30% reduction in pain · adults with neuropathic pain
1 finding from 1 review
no estimate extracted
62 participants
Very low
At least 50% reduction in pain · adults with neuropathic pain
1 finding from 1 review
no estimate extracted
62 participants
Very low
Patient Global Impression of Change much or very much improved · adults with neuropathic pain
1 finding from 1 review
Any pain‐related outcome (moderate pain improvement) · adults with neuropathic pain
It is very uncertain whether morphine changes any pain‐related outcome (moderate pain improvement) compared with placebo (very low certainty).
1 finding from 1 review
Serious adverse events · adults with neuropathic pain
1 finding from 1 review
Death · adults with neuropathic pain
1 finding from 1 review
Any adverse event · adults with neuropathic pain
1 finding from 1 review
Withdrawal (all‐cause) · adults with neuropathic pain
It is very uncertain whether morphine changes all‐cause withdrawal compared with placebo (very low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · patients undergoing knee arthroscopy
3 findings from 1 review
no estimate extracted
7 studies · 297 participants
Low
no estimate extracted
7 studies · 297 participants
Low
no estimate extracted
7 studies · 297 participants
Low
Adverse eventsPercentage of participants with any adverse event · patients undergoing knee arthroscopy
Morphine showed no clear difference in adverse eventsPercentage of participants with any adverse event compared with bupivacaine (moderate certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · patients undergoing knee arthroscopy
3 findings from 1 review
no estimate extracted
2 studies · 80 participants
Very low
no estimate extracted
2 studies · 80 participants
Low
no estimate extracted
2 studies · 80 participants
Low
Analgesia durationTime duration from the end of surgery to the time of first analgesic consumption. Scale from: 0 to 100. · patients undergoing knee arthroscopy
1 finding from 1 review
Adverse eventsPercentage of participants with any adverse event · patients undergoing knee arthroscopy
Morphine showed no clear difference in adverse eventsPercentage of participants with any adverse event compared with NSAIDs (moderate certainty).
1 finding from 1 review
Analgesia durationTime duration from the end of surgery to the time of first analgesic consumption. Scale from: 0 to 100. · patients undergoing knee arthroscopy
1 finding from 1 review
Adverse eventsPercentage of participants with any adverse event · patients undergoing knee arthroscopy
Morphine showed no clear difference in adverse eventsPercentage of participants with any adverse event compared with placebo (low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · patients undergoing knee arthroscopy
3 findings from 1 review
no estimate extracted
5 studies · 248 participants
Low
no estimate extracted
6 studies · 330 participants
Low
no estimate extracted
5 studies · 270 participants
Low
Analgesia durationTime duration from the end of surgery to the time of first analgesic consumption. Scale from: 0 to 100. · patients undergoing knee arthroscopy
1 finding from 1 review